Glaucoma is a neurodegenerative disease that involves a group of eye-related neuropathies with a progressive nature and is caused due to slow destruction of retinal ganglion cells (RGCs). Glaucoma affects the retinal deposition of Beta-amyloid, phosphorylated Tau protein (pTau), and synuclein. The condition causes the reduction of visual field and functional impairment in the patient, which is attributed to the progressive nature of axonal degeneration in the retina [1].